Literature DB >> 2607058

Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance.

M D Rapport1, S O Quinn, G J DuPaul, E P Quinn, K L Kelly.   

Abstract

This investigation examined the relationship between methylphenidate (MPH) and the learning and recall of paired associations by children with attention deficit disorder with hyperactivity (ADDH). Forty-five children with ADDH were randomly assigned to one of three groups (novel, partial mastery, and mastery learning) that varied in the amount of previous learning of paired associations and participated in a double-blind, placebo-control, repeated-measures-across-dose (crossover) design. Each child received four doses of MPH (5 mg, 10 mg, 15 mg, and 20 mg) and a placebo in a random, counterbalanced sequence. The results indicated that both the rate of acquisition and accuracy in learning paired associations were significantly, but differentially, affected by MPH dose and the degree of learning mastery. The implications of these results for psychopharmacological research and the monitoring of psychostimulant effects on children's learning performance in academic settings are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2607058     DOI: 10.1007/bf00917730

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  25 in total

1.  Recall, retention, and ritalin.

Authors:  E D Rie; H E Rie
Journal:  J Consult Clin Psychol       Date:  1977-12

2.  State-dependent and main effects of methylphenidate and pemoline on paired-associate learning and spelling in hyperactive children.

Authors:  R S Stephens; W E Pelham; R Skinner
Journal:  J Consult Clin Psychol       Date:  1984-02

3.  Trends in medication treatment of hyperactive school children. Results of six biannual surveys.

Authors:  D J Safer; J M Krager
Journal:  Clin Pediatr (Phila)       Date:  1983-07       Impact factor: 1.168

4.  Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies.

Authors:  J M Swanson
Journal:  Psychopharmacol Bull       Date:  1985

5.  Cognitive processes in normal and hyperactive children and their response to amphetamine treatment.

Authors:  H Weingartner; J L Rapoport; M S Buchsbaum; W E Bunney; M H Ebert; E J Mikkelsen; E D Caine
Journal:  J Abnorm Psychol       Date:  1980-02

6.  Methylphenidate in hyperactive children: differential effects of dose on academic, learning, and social behavior.

Authors:  M D Rapport; G Stoner; G J DuPaul; B K Birmingham; S Tucker
Journal:  J Abnorm Child Psychol       Date:  1985-06

7.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

Authors:  J L Rapoport; M S Buchsbaum; H Weingartner; T P Zahn; C Ludlow; E J Mikkelsen
Journal:  Arch Gen Psychiatry       Date:  1980-08

8.  Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity.

Authors:  J Swanson; M Kinsbourne; W Roberts; K Zucker
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

9.  Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior.

Authors:  R L Sprague; E K Sleator
Journal:  Science       Date:  1977-12-23       Impact factor: 47.728

10.  Effects of methylphenidate (Ritalin) on selective attention in hyperactive children.

Authors:  C M Thurston; M P Sobol; J Swanson; M Kinsbourne
Journal:  J Abnorm Child Psychol       Date:  1979-12
View more
  4 in total

Review 1.  Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?

Authors:  Joshua M Langberg; Stephen P Becker
Journal:  Clin Child Fam Psychol Rev       Date:  2012-09

2.  The multifaceted effects of oral administration of methylphenidate in juvenile rats: anxiety, activity, and attention.

Authors:  Ning Zhu; Jeremy Weedon; Diana L Dow-Edwards
Journal:  Eur Neuropsychopharmacol       Date:  2010-01-18       Impact factor: 4.600

Review 3.  Drug therapy for adults with attention-deficit hyperactivity disorder.

Authors:  Timothy E Wilens
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.